Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Immunobiology

A cholesterol-dependent CD20 epitope detected by the FMC7 antibody

Leukemia volume 17, pages 1384–1389 (2003)Cite this article

Abstract

Accurate diagnosis of lymphoid malignancies is essential for appropriate therapeutic intervention. In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage. Recent evidence suggesting that CD20 predicts FMC7 expression has prompted reappraisal of the utility of monitoring both markers. Here, we report that the FMC7 monoclonal antibody (mAb) specifically and strongly recognized CD20 ectopically expressed in hematopoietic and nonhematopoietic cell lines. The reactivity of FMC7 was abolished by mutations in the extracellular domain of CD20. These data confirm the CD20 specificity of FMC7. Like other CD20 mAbs, FMC7 binding was temperature dependent and induced detergent insolubility of CD20. Of significant interest, the CD20 epitope recognized by FMC7 was unusual in that it was exceptionally sensitive to membrane cholesterol. Cholesterol depletion profoundly reduced expression of the FMC7 epitope, whereas cholesterol enrichment enhanced its expression. FMC7 mAb binding thus appears to be a sensitive indicator of the level of plasma membrane cholesterol and reveals a conformational state of CD20 that is regulated by cholesterol.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640–1645.

    CAS  Google Scholar 

  2. DiGiuseppe JA, Borowitz MJ . Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 1998; 25: 6–10.

    CAS  PubMed  Google Scholar 

  3. D'Arena G, Musto P, Cascavilla N, Dell'Olio M, Di Renzo N, Carotenuto M . Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders. Am J Hematol 2000; 64: 275–281.

    Article  Google Scholar 

  4. Garcia DP, Rooney MT, Ahmad E, Davis BH . Diagnostic usefulness of CD23 and FMC-7 antigen expression patterns in B-cell lymphoma classification. Am J Clin Pathol 2001; 115: 258–265.

    Article  CAS  Google Scholar 

  5. Serke S, Schwaner I, Yordanova M, Szczepek A, Huhn D . Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses. Cytometry 2001; 46: 98–104.

    Article  CAS  Google Scholar 

  6. Rosenthal P, Rimm IJ, Umiel T, Griffin JD, Osathanondh R, Schlossman SF et al. Ontogeny of human hematopoietic cells: analysis utilizing monoclonal antibodies. J Immunol 1983; 131: 232–237.

    CAS  PubMed  Google Scholar 

  7. Brooks DA, Beckman IG, Bradley J, McNamara PJ, Thomas ME, Zola H . Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. J Immunol 1981; 126: 1373–1377.

    CAS  PubMed  Google Scholar 

  8. Zola H, McNamara PJ, Moore HA, Smart IJ, Brooks DA, Beckman IG et al. Maturation of human B lymphocytes – studies with a panel of monoclonal antibodies against membrane antigens. Clin Exp Immunol 1983; 52: 655–664.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Bloem AC, Chand MA, Dollekamp I, Rijkers GT . Functional properties of human B-cell subpopulations defined by monoclonal antibodies HB4 and FMC7. J Immunol 1988; 140: 768–773.

    CAS  PubMed  Google Scholar 

  10. Rijkers GT, Dollekamp I, Zegers BJ . Evidence that FMC7 is a human B-cell differentiation antigen. Immunol Lett 1990; 24: 261–264.

    Article  CAS  Google Scholar 

  11. Hubl W, Iturraspe J, Braylan RC . FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20. Cytometry 1998; 34: 71–74.

    Article  CAS  Google Scholar 

  12. Zola H, Neoh SH, Potter A, Melo JV, De Oliveria MS, Catovsky D . Markers of differentiated B-cell leukaemia: CD22 antibodies and FMC7 react with different molecules. Dis Markers 1987; 5: 227–235.

    CAS  PubMed  Google Scholar 

  13. Catovsky D, Cherchi M, Brookss D, Bradely J, Zola H . Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7. Blood 1981; 58: 406–408.

    CAS  PubMed  Google Scholar 

  14. Huh YO, Pugh WC, Kantarjian HM, Stass SA, Cork A, Trujillo JM et al. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody. Am J Clin Pathol 1994; 101: 283–289.

    Article  CAS  Google Scholar 

  15. Scott CS, Limbert HJ, MacKarill ID, Roberts BE . Membrane phenotypic studies in B-cell lymphoproliferative disorders. J Clin Pathol 1985; 38: 995–1001.

    Article  CAS  Google Scholar 

  16. Almasri NM, Duque RE, Iturraspe J, Everett E, Braylan RC . Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992; 40: 259–263.

    Article  CAS  Google Scholar 

  17. D'Hautcourt JL, Isaac J . Mean fluorescence intensity of dual stained cells. Cytometry 1999; 38: 44–46.

    Article  CAS  Google Scholar 

  18. Ahmad E, Garcia D, Davis BH . Clinical utility of CD23 and FMC7 antigen coexistent expression in B-cell lymphoproliferative disorder subclassification. Cytometry 2002; 50: 1–7.

    Article  CAS  Google Scholar 

  19. Deans JP, Kalt L, Ledbetter JA, Schieven GL, Bolen JB, Johnson P . Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B-cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20. J Biol Chem 1995; 270: 22632–22638.

    Article  CAS  Google Scholar 

  20. Polyak MJ, Deans JP . Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure. Blood 2002; 99: 3256–3262.

    Article  CAS  Google Scholar 

  21. Karasuyama H, Kudo A, Melchers F . The proteins encoded by the VpreB and lambda 5 pre- B-cell -specific genes can associate with each other and with mu heavy chain. J Exp Med 1990; 172: 969–972.

    Article  CAS  Google Scholar 

  22. Deans JP, Robbins SM, Polyak MJ, Savage JA . Rapid redistribution of CD20 to a low density detergent-insoluble membrane compartment. J Biol Chem 1998; 273: 344–348.

    Article  CAS  Google Scholar 

  23. Inbar M . Fluidity of membrane lipids: a single cell analysis of mouse normal lymphocytes and malignant lymphoma cells. FEBS Lett 1976; 67: 180–185.

    Article  CAS  Google Scholar 

  24. Ohtani Y, Irie T, Uekama K, Fukunaga K, Pitha J . Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem 1989; 186: 17–22.

    Article  CAS  Google Scholar 

  25. Yancey PG, Rodrigueza WV, Kilsdonk EP, Stoudt GW, Johnson WJ, Phillips MC et al. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J Biol Chem 1996; 271: 16026–16034.

    Article  CAS  Google Scholar 

  26. Simons K, Ikonen E . Functional rafts in cell membranes. Nature 1997; 387: 569–572.

    Article  CAS  Google Scholar 

  27. Brown DA, London E . Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000; 275: 17221–17224.

    Article  CAS  Google Scholar 

  28. Gimpl G, Burger K, Politowska E, Ciarkowski J, Fahrenholz F . Oxytocin receptors and cholesterol: interaction and regulation. Exp Physiol 2000; 85: 41S–49S.

    Article  CAS  Google Scholar 

  29. Jones OT, McNamee MG . Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry 1988; 27: 2364–2374.

    Article  CAS  Google Scholar 

  30. Klein U, Gimpl G, Fahrenholz F . Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 1995; 34: 13784–13793.

    Article  CAS  Google Scholar 

  31. Fahrenholz F, Klein U, Gimpl G . Conversion of the myometrial oxytocin receptor from low to high affinity state by cholesterol. Adv Exp Med Biol 1995; 395: 311–319.

    CAS  PubMed  Google Scholar 

  32. Narayanaswami V, McNamee MG . Protein-lipid interactions and Torpedo californica nicotinic acetylcholine receptor function. 2. Membrane fluidity and ligand-mediated alteration in the accessibility of gamma subunit cysteine residues to cholesterol. Biochemistry 1993; 32: 12420–12427.

    Article  CAS  Google Scholar 

  33. Bubien JK, Zhou LJ, Bell PD, Frizzell RA, Tedder TF . Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes. J Cell Biol 1993; 121: 1121–1132.

    Article  CAS  Google Scholar 

  34. Kanzaki M, Shibata H, Mogami H, Kojima I . Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells. J Biol Chem 1995; 270: 13099–13104.

    Article  CAS  Google Scholar 

  35. Deans JP, Kalt L, Ledbetter JA, Schieven GL, Bolen JB, Johnson P . Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B-cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20. J Biol Chem 1995; 270: 22632–22638.

    Article  CAS  Google Scholar 

  36. Popoff IJ, Savage JA, Blake J, Johnson P, Deans JP . The association between CD20 and Src-family tyrosine kinases requires an additional factor. Mol Immunol 1998; 35: 207–214.

    Article  CAS  Google Scholar 

  37. Deans JP, Li H, Polyak MJ . CD20-mediated apoptosis: signalling through lipid rafts. Immunology 2002; 107: 176–182.

    Article  CAS  Google Scholar 

  38. Hofmeister JK, Cooney D, Coggeshall KM . Clustered CD20 induced apoptosis: src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis. Blood Cells Mol Dis 2000; 26: 133–143.

    Article  CAS  Google Scholar 

  39. Shan D, Ledbetter JA, Press OW . Signaling events involved in anti-CD20-induced apoptosis of malignant human B-cells. Cancer Immunol Immunother 2000; 48: 673–683.

    Article  CAS  Google Scholar 

  40. Maloney DG, Smith B, Rose A . Rituximab: mechanism of action and resistance. Semin Oncol 2002; 29: 2–9.

    Article  CAS  Google Scholar 

  41. Cragg MS, Morgan SM, Chan HT, Morgan BP, Filatov AV, Johnson PW et al. Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts. Blood 2003; 101: 1045–1052.

    Article  CAS  Google Scholar 

  42. Sherbet GV . Membrane fluidity and cancer metastasis. Exp Cell Biol 1989; 57: 198–205.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank L Robertson for assistance with flow cytometry and Dr A Kossakowska for helpful comments on the manuscript. JPD is an Alberta Heritage Foundation for Medical Research Senior Scholar. This research was supported by the Canadian Institutes of Health Research.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Immunology Research Group, University of Calgary, Calgary, Alberta, Canada

    M J Polyak, L M Ayer & J P Deans

  2. Department of Molecular Biology, Max-Planck-Institute for Infection Biology, Berlin, Germany

    A J Szczepek

Authors
  1. M J Polyak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L M Ayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A J Szczepek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J P Deans
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This paper is dedicated to the memory of Dr Stefan Serke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Polyak, M., Ayer, L., Szczepek, A. et al. A cholesterol-dependent CD20 epitope detected by the FMC7 antibody. Leukemia 17, 1384–1389 (2003). https://doi.org/10.1038/sj.leu.2402978

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402978

Keywords

Search

Advanced search

Quick links